Blueprint Medicines Corp (DELISTED) (BPMC:DL)
129.46
0.00 (0.00%)
USD |
NASDAQ |
Jul 28, 16:00
Blueprint Medicines Shareholders Equity (Quarterly): 342.13M for March 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 233.89M |
| TG Therapeutics, Inc. | 607.22M |
| AVITA Medical, Inc. | -6.666M |
| Ardelyx, Inc. | 154.28M |
| Bristol Myers Squibb Co. | 18.55B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.196B |
| Total Liabilities (Quarterly) | 853.47M |
| Debt to Equity Ratio | 1.133 |
| Current Ratio | 2.802 |
| Net Debt Paydown Yield | -0.52% |